JP7149929B2 - 未精製膜からのサポシンリポタンパク質粒子およびライブラリー - Google Patents

未精製膜からのサポシンリポタンパク質粒子およびライブラリー Download PDF

Info

Publication number
JP7149929B2
JP7149929B2 JP2019509544A JP2019509544A JP7149929B2 JP 7149929 B2 JP7149929 B2 JP 7149929B2 JP 2019509544 A JP2019509544 A JP 2019509544A JP 2019509544 A JP2019509544 A JP 2019509544A JP 7149929 B2 JP7149929 B2 JP 7149929B2
Authority
JP
Japan
Prior art keywords
membrane
particles
lipid
lipids
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019509544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019529360A5 (https=
JP2019529360A (ja
Inventor
フラウエンフェルト，イェンス
レーヴィング，ロビン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salipro Biotech AB
Original Assignee
Salipro Biotech AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salipro Biotech AB filed Critical Salipro Biotech AB
Publication of JP2019529360A publication Critical patent/JP2019529360A/ja
Publication of JP2019529360A5 publication Critical patent/JP2019529360A5/ja
Priority to JP2022116793A priority Critical patent/JP7460700B2/ja
Application granted granted Critical
Publication of JP7149929B2 publication Critical patent/JP7149929B2/ja
Priority to JP2024044505A priority patent/JP7702167B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0012—Lipids; Lipoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
JP2019509544A 2016-08-19 2017-08-21 未精製膜からのサポシンリポタンパク質粒子およびライブラリー Active JP7149929B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022116793A JP7460700B2 (ja) 2016-08-19 2022-07-22 未精製膜からのサポシンリポタンパク質粒子およびライブラリー
JP2024044505A JP7702167B2 (ja) 2016-08-19 2024-03-21 未精製膜からのサポシンリポタンパク質粒子およびライブラリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16184843.7 2016-08-19
EP16184843.7A EP3284460A1 (en) 2016-08-19 2016-08-19 Saposin lipoprotein particles and libraries from crude membranes
PCT/EP2017/071043 WO2018033647A1 (en) 2016-08-19 2017-08-21 Saposin lipoprotein particles and libraries from crude membranes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022116793A Division JP7460700B2 (ja) 2016-08-19 2022-07-22 未精製膜からのサポシンリポタンパク質粒子およびライブラリー

Publications (3)

Publication Number Publication Date
JP2019529360A JP2019529360A (ja) 2019-10-17
JP2019529360A5 JP2019529360A5 (https=) 2020-09-17
JP7149929B2 true JP7149929B2 (ja) 2022-10-07

Family

ID=56740926

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019509544A Active JP7149929B2 (ja) 2016-08-19 2017-08-21 未精製膜からのサポシンリポタンパク質粒子およびライブラリー
JP2022116793A Active JP7460700B2 (ja) 2016-08-19 2022-07-22 未精製膜からのサポシンリポタンパク質粒子およびライブラリー
JP2024044505A Active JP7702167B2 (ja) 2016-08-19 2024-03-21 未精製膜からのサポシンリポタンパク質粒子およびライブラリー

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022116793A Active JP7460700B2 (ja) 2016-08-19 2022-07-22 未精製膜からのサポシンリポタンパク質粒子およびライブラリー
JP2024044505A Active JP7702167B2 (ja) 2016-08-19 2024-03-21 未精製膜からのサポシンリポタンパク質粒子およびライブラリー

Country Status (9)

Country Link
US (1) US11346843B2 (https=)
EP (2) EP3284460A1 (https=)
JP (3) JP7149929B2 (https=)
CN (1) CN109640960B (https=)
CA (1) CA3034136A1 (https=)
DK (1) DK3463303T3 (https=)
ES (1) ES2797257T3 (https=)
PT (1) PT3463303T (https=)
WO (1) WO2018033647A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3725304A1 (en) 2019-04-15 2020-10-21 Salipro Biotech AB Production of salipro particles
CN110483618B (zh) * 2019-09-11 2022-09-09 青岛科技大学 杂[4]芳烃衍生物及其制备和应用
CN111040019B (zh) * 2019-12-25 2022-06-07 上海交通大学 一种用于与TfR蛋白特异性结合的配体多肽及其应用
TW202242114A (zh) 2020-12-23 2022-11-01 美商再生元醫藥公司 用於獲得結合至跨膜蛋白之抗體以及抗體生成細胞的方法
US20220268785A1 (en) * 2021-02-19 2022-08-25 Northwestern University Facile sample preparation for quantitative single-cell proteomics
WO2023001912A1 (en) 2021-07-22 2023-01-26 Salipro Biotech AB Methods for structure determination and drug design using salipro particles
EP4123307A1 (en) 2021-07-22 2023-01-25 Salipro Biotech AB Methods for structure determination and drug design using salipro particles

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016504312A (ja) 2012-12-18 2016-02-12 フラウエンフェルト イェンスＦＲＡＵＥＮＦＥＬＤ， Ｊｅｎｓ Ｓａｌｉｐｒｏ粒子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872406B2 (en) * 2000-02-11 2005-03-29 Children's Hospital Research Foundation Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems
DK1345959T3 (da) 2000-11-20 2011-09-05 Univ Illinois Membranscaffoldproteiner
EP2314285B2 (en) 2003-02-14 2019-09-18 Children's Hospital & Research Center at Oakland Lipophilic drug delivery vehicle and methods of use thereof
CN103585105A (zh) * 2008-11-07 2014-02-19 儿童医院医疗中心 用于跨膜药物递送系统的鞘脂激活蛋白c以及相关蛋白和肽促融合性质
GB0913823D0 (en) 2009-08-07 2009-09-16 Isis Innovation Bilayers
LT3043814T (lt) 2013-09-13 2021-02-25 Salipro Biotech AB Antigenas ir jo gamybos būdas

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016504312A (ja) 2012-12-18 2016-02-12 フラウエンフェルト イェンスＦＲＡＵＥＮＦＥＬＤ， Ｊｅｎｓ Ｓａｌｉｐｒｏ粒子

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Nat. Methods，Vol. 13, No. 4，pp.345-351

Also Published As

Publication number Publication date
JP2024096708A (ja) 2024-07-17
EP3463303A1 (en) 2019-04-10
JP7702167B2 (ja) 2025-07-03
ES2797257T3 (es) 2020-12-01
US20190204337A1 (en) 2019-07-04
CN109640960A (zh) 2019-04-16
JP7460700B2 (ja) 2024-04-02
WO2018033647A1 (en) 2018-02-22
CA3034136A1 (en) 2018-02-22
JP2019529360A (ja) 2019-10-17
EP3284460A1 (en) 2018-02-21
PT3463303T (pt) 2020-06-18
US11346843B2 (en) 2022-05-31
DK3463303T3 (da) 2020-06-15
EP3463303B1 (en) 2020-03-11
JP2022163077A (ja) 2022-10-25
CN109640960B (zh) 2022-08-12

Similar Documents

Publication Publication Date Title
JP7702167B2 (ja) 未精製膜からのサポシンリポタンパク質粒子およびライブラリー
DK2745834T3 (en) Salipro particles
EP3484912B1 (en) Methods and compositions relating to covalently circularized nanodiscs
EP3955895B1 (en) Production of salipro particles
Justesen et al. Active plasma membrane P-type H+-ATPase reconstituted into nanodiscs is a monomer
US20220270707A1 (en) Saposin lipoprotein particles and libraries from crude membranes
CA3136842C (en) Production of salipro particles
van ‘t Klooster et al. Periprotein membrane lipidomics and the role of lipids in transporter function in yeast

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200806

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200806

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210622

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210915

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211119

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220722

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220722

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220810

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220816

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220906

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220927

R150 Certificate of patent or registration of utility model

Ref document number: 7149929

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250